Cargando…
Mitoxantrone in NMO Spectrum Disorder in a Large Multicenter Cohort in French Caribbean
BACKGROUND AND OBJECTIVES: Preventing relapses in neuromyelitis Optica spectrum disorder (NMOSD) is a primary goal. New effective molecules are often expensive and not readily available in regions with fragile health systems. Assessing the efficacy and safety of less costly therapeutic alternatives...
Autores principales: | Chaumont, Hugo, Bérard, Nicolas, Karam, Jean-Pierre, Lobjois, Quentin, Tressieres, Benoit, Signate, Aissatou, Lannuzel, Annie, Cabre, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691227/ https://www.ncbi.nlm.nih.gov/pubmed/37949668 http://dx.doi.org/10.1212/NXI.0000000000200175 |
Ejemplares similares
-
NMOSD-like and longitudinal extensive HTLV1-associated myelitis are extremes that flank an overlooked continuum
por: Bonnan, Mickael, et al.
Publicado: (2021) -
Therapy of NMO spectrum disorders
por: Biswas, Atanu, et al.
Publicado: (2015) -
COVID-19 infection in NMO/SD patients: a French survey
por: Zeidan, Sinéad, et al.
Publicado: (2020) -
Finding NMO
por: Daneman, Richard
Publicado: (2016) -
Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
por: Borisow, Nadja, et al.
Publicado: (2018)